Cargando…
Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies
Decreased level of high density-lipoprotein cholesterol (HDL-C) is a rigorous predictor for future cardiovascular events. Much effort is being made to develop HDL-C–raising pharmacotherapies in the attempt to avert the pandemic of atherosclerotic disease. Important properties by which HDL-C–raising...
Autores principales: | Duivenvoorden, Raphaël, Fayad, Zahi A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085734/ https://www.ncbi.nlm.nih.gov/pubmed/21465111 http://dx.doi.org/10.1007/s11883-011-0176-1 |
Ejemplares similares
-
Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation
por: Alie, Nadia, et al.
Publicado: (2015) -
Conformational Changes in High-Density Lipoprotein
Nanoparticles Induced by High Payloads of Paramagnetic Lipids
por: Ramos-Cabrer, Pedro, et al.
Publicado: (2016) -
High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012) -
High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020) -
A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)